en
02 229 52 30
Newsletter

Life sciences & care

Within PMV, we are the centre of expertise in Life Sciences & Care.

We invest in companies with a solid business plan, that address a clearly defined unmet need and have a strong competitive advantage.

We connect innovative science and technology with outstanding teams, aiming to achieve both financial return and societal impact.

By leveraging our specialised team and broad network of experts, we build leading sustainable companies that can play a significant role, both in our local ecosystem and worldwide.

Confo Therapeutics

Characteristics

Focus

Pioneering innovations that offer scalable solutions with a strong ambition to strengthen the local ecosystem

Approach

Evergreen investor with hands-on mentality
Entry level: from seed round/early stage to growth/IPO
Tickets: up to €25 million over the lifespan of a company

Target industries

Therapeutics, agbiotech, digital health, medical technologies

Roeland Pelgrims, CEO van Nobi

Each and every one of our investors combines highly credible capital with very accessible mentorship.

Roeland Pelgrims, founder and CEO Nobi

Team Life Sciences & Care

Bart De Taeye Investment Director bart.detaeye@pmv.eu +32 (0)2 229 52 30
KNI
Kelly Niesing Management assistant kelly.niesing@pmv.eu +32 (0)2 229 52 30
Kenneth Wils Head of Life Sciences & Care info@pmv.eu +32 (0)2 229 52 30
Nathalie Van Bruaene Senior investment manager nathalie.vanbruaene@pmv.eu +32 (0)2 229 52 30
Thomas Beke Investment manager thomas.beke@pmv.eu +32 (0)2 229 52 30
Tine Bekaert Senior Investment Manager tine.bekaert@pmv.eu +32 (0)2 229 52 30
Aline Van Acker Investeringsmanager aline.vanacker@pmv.eu +32 (0)2 229 52 30
Hava Izci Investeringsanalist +32 (0)2 229 52 30
Kiana Buttiens Investeringsanalist kiana.buttiens@pmv.eu +32 (0)2 229 52 30
Rindert Missiaen Investeringsmanager rindert.missiaen@pmv.eu 02 229 52 30
Tobias Wilms Investeringsmanager tobias.wilms@pmv.eu +32 (0)2 229 52 30